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Abstract. 
 
The budding yeast contains two type I myo-
sins, Myo3p and Myo5p, with redundant functions. De-
letion of both myosins results in growth defects, loss of 
actin polarity and polarized cell surface growth, and ac-
cumulation of intracellular membranes. Expression of 
myc-tagged Myo5p in 
 
myo3
 
D
 
 myo5
 
D
 
 
 
cells fully restores 
wild-type characteristics. Myo5p is localized as punc-
tate, cortical structures enriched at sites of polarized 
cell growth. We find that latrunculin-A–induced depo-
 
lymerization of F-actin results in loss of Myo5p patches.
 
 
 
Moreover, incubation of yeast cells at 37
 
8
 
C results in 
transient depolarization of both Myo5p patches and the 
actin cytoskeleton. Mutant Myo5 proteins with dele-
tions in nonmotor domains were expressed in 
 
myo3
 
D
 
 
myo5
 
D
 
 
 
cells and the resulting strains were analyzed for 
Myo5p function. Deletion of the tail homology 2 (TH2) 
domain, previously implicated in ATP-insensitive actin 
binding, has no detectable effect on Myo5p function. In 
contrast, 
 
myo3
 
D
 
 myo5
 
D
 
 
 
cells expressing mutant Myo5 
proteins with deletions of the src homology domain 3 
(SH3) or both TH2 and SH3 domains display defects 
including Myo5p patch depolarization, actin disorgani-
zation, and phenotypes associated with actin dysfunc-
tion. These findings support a role for the SH3 domain 
in Myo5p localization and function in budding yeast. 
The proline-rich protein verprolin (Vrp1p) binds to the 
SH3 domain of Myo3p or Myo5p in two-hybrid tests, 
coimmunoprecipitates with Myo5p, and colocalizes 
with Myo5p. Immunolocalization of the myc-tagged 
SH3 domain of Myo5p reveals diffuse cytoplasmic 
staining. Thus, the SH3 domain of Myo5p contributes 
to but is not sufficient for localization of Myo5p either 
to patches or to sites of polarized cell growth. Consis-
tent with this, Myo5p patches assemble but do not lo-
calize to sites of polarized cell surface growth in a 
 
VRP1 
 
deletion mutant. Our studies support a multistep 
model for Myo5p targeting in yeast. The first step, as-
sembly of Myo5p patches, is dependent upon F-actin, 
and the second step, polarization of actin patches, 
requiresVrp1p and the SH3 domain of Myo5p.
 
T
 
he
 
 myosin superfamily of molecular motors has a
crucial role in actin-dependent processes in all eu-
karyotic cells. This superfamily consists of conven-
tional (type II or muscle-like) myosins and at least ten
classes of unconventional myosins (for review see Cheney
and Mooseker, 1995; Sellers and Goodson, 1995). All un-
conventional myosin proteins have conserved “head” and
“neck” regions. The head or motor domain contains bind-
ing sites for ATP and actin. The necks of myosin proteins
have a variable number of isoleucine- and glutamine-rich
IQ motifs, possible binding sites for calmodulin or calmod-
ulin-like light chains. The carboxy-terminal “tail” regions,
which are highly divergent among classes of unconventional
myosins, contain sequences implicated in protein–protein
interactions, membrane binding, and intracellular signaling.
The type I myosin proteins were the first unconven-
tional myosins to be discovered and remain the best stud-
ied class (Pollard and Korn, 1973). Representatives of this
class are present in phylogenetically diverse organisms in-
cluding filamentous fungi, ameba, yeast, and vertebrates.
This points to a central role for these proteins in eukary-
otic cell function (for review see Cheney and Mooseker,
1995). Phylogenetic sequence comparisons of the head re-
gions of a host of novel myosins-I reveals at least four sub-
classes. Our study focuses on the subclass of myosins-I
known as “classic” or “ameboid” myosins-I.
In 
 
Saccharomyces cerevisiae
 
, there are two highly re-
lated classic type I myosin isoforms, 
 
MYO3
 
 and 
 
MYO5
 
,
which appear to have overlapping activities (Goodson and
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Spudich, 1995; Goodson et al., 1996). Deletion of 
 
MYO3
 
or 
 
MYO5
 
 alone leads to only subtle defects. In contrast,
deletion of both 
 
MYO3
 
 and 
 
MYO5
 
 results in severe de-
fects in actin organization and phenotypes associated with
actin cytoskeletal dysfunction including slow growth, accu-
mulation of intracellular membranes and vesicles, cell
rounding, random bud site selection, and impaired secre-
tion and endocytosis (Geli and Riezman, 1996; Goodson
et al., 1996). Myo5p is localized as punctate, cortical struc-
tures that are enriched at sites of polarized growth and ac-
tin cytoskeletal polarization. These observations support a
general role for Myo5p in organization of the yeast actin
cytoskeleton.
Recent studies also support a role for the classic myosin
I of 
 
Dictyostelium discoideum
 
, myoB, in control of actin
organization (Temesvari et al., 1996). Moreover, other
classic myosin I proteins have been implicated in a variety
of processes that are dependent upon actin cytoskeletal
function (Jung and Hammer, 1990; Jung et al., 1993, 1996;
Titus et al., 1993; Peterson et al., 1995; Novak et al., 1995;
McGoldrick et al., 1995; Goodson et al., 1996). myoB,
myoC, and myoD of 
 
Dictyostelium 
 
contribute to endocy-
tosis, motility, streaming, and phagocytosis (Jung and
Hammer, 1990; Titus et al., 1993; Jung et al., 1996). myoA,
a classic type I myosin that is essential for viability in 
 
As-
pergillus nidulans, 
 
is required for polarized growth and se-
cretion (McGoldrick et al., 1995). Finally, myosin IC of
 
Acanthamoeba castellani 
 
is essential for contractile vacu-
ole function (Doberstein et al., 1993).
Consistent with this, classic myosin I proteins in yeast
and other organisms (Fukui et al., 1989; Jung et al., 1993;
Baines et al., 1995; McGoldrick et al., 1995; Goodson et al.,
1996) are localized to actin-rich regions or sites of actin re-
organization. First, many other myosin I proteins includ-
ing myosin IC of 
 
Acanthamoeba
 
, myoA and B of 
 
Dictyo-
stelium,
 
 and myoA of 
 
Aspergillus 
 
display cortical localization.
Second, classic myosin I proteins are localized at sites of
actin organization in budding yeast, 
 
Aspergillus
 
, and 
 
Dic-
tyostelium
 
. Third, the classic myosin I protein of 
 
Aspergil-
lus
 
 occurs in punctate structures similar to cortical Myo5p
patches of budding yeast.
Here, we report studies on the role of the tail homology
domain 2 (TH2)
 
1
 
 and src homology domain 3 (SH3) do-
mains of the Myo5p tail in Myo5p-control of actin organi-
zation and function in vivo. These regions are present in
all classic myosin I proteins; however, their contribution to
myosin I function within the context of the cell is not well
understood (for review see Sellers and Goodson, 1995).
The TH2 domain is a glycine-proline-alanine–rich region
implicated in ATP-insensitive actin binding and actin
cross-linking in vitro (Lynch et al., 1986; Pollard et al.,
1991; Jung and Hammer, 1994; Rosenfeld and Rener,
1994). The SH3 domain, a region that binds proline-rich
sequences, has been implicated in a variety of cell func-
tions. Early studies indicate that the SH3 domain mediates
protein–protein interactions that regulate enzymatic activ-
ity. For example, binding of p85 to the SH3 domain of
 
phosphatidylinositol-3
 
9
 
 kinase (PI-3 kinase) increases PI-3
kinase activity five- to sevenfold (Pleiman et al., 1994).
Since classic myosin I proteins contain proline-rich regions
within their TH2 domain, it is possible that their SH3 do-
main participates in intramolecular links which regulate
function (Goodson and Spudich, 1995). Other studies indi-
cate that the SH3 domain contributes to protein targeting.
For example, SH3 domains of the NADPH oxidase sub-
units, p47phox and p67phox, mediate protein–protein in-
teractions required to recruit p47phox and p67phox to the
membrane to form an activated oxidase (de Mendez et al.,
1994, 1996). Moreover, microinjection studies with the
SH3 domain of phospholipase C-
 
g
 
 indicate that the SH3
domain mediates localization of phospholipase C-
 
g
 
 to the
microfilament network (Bar-Sagi et al., 1993). Indeed,
many cytoskeleton-associated proteins including myosin I
(Bement et al., 1994; Stoffler et al., 1995; Goodson and
Spudich, 1995; Goodson et al., 1996), fodrin (Merilainen
et al., 1993), nebulin (Wang et al., 1996), cortactin (Wu
and Parsons, 1993), and the actin-associated proteins of
yeast Abp1p (Drubin et al., 1990; Lila and Drubin, 1997),
Rvs167p (Bauer et al., 1993), Bem1p (Chenevert et al.,
1993), Boi1p and Boi2p (Bender et al., 1996; Matsui et al.,
1996) contain SH3 domains, which underscores the impor-
tance of the SH3 domain in protein–protein interactions
with the cytoskeleton.
We find that the SH3 domain is critical for Myo5p patch
polarization and Myo5p-dependent actin organization,
and identify Vrp1p as a likely binding partner for the SH3
domain of yeast myosin I proteins. Moreover, we find that
targeting of Myo5p in yeast is a multistep process.
 
Materials and Methods
 
Yeast and Bacterial Manipulations
 
S. cerevisiae
 
 strains used in this study are the following: (
 
a
 
) HA10-1b
(wild-type), MAT
 
a
 
 
 
can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1
 
(Goodson and Spudich, 1995); (
 
b
 
) HA31-9c (
 
myo3
 
D
 
 myo5
 
D
 
), MAT
 
a
 
can1-100 ade2-1 his3-11 leu2-3,112 ura3-1 trp1-1 myo3::HIS3 myo5::TRP1
 
;
(
 
d
 
) HA31-9a (
 
myo3
 
D
 
)
 
, and (
 
e
 
) MAT
 
a
 
 
 
can1-100 ade2-1 his3-11 leu2-3,112
ura3-1 trp1-1 myo3::HIS3
 
 (Goodson et al., 1996). VHA-1 is an HA31-9c–
derived strain in which the DNA encoding three copies of the hemaggluti-
nin (HA) tag was inserted into the 3
 
9
 
 end of the chromosomal copy of the
 
VRP1 
 
gene (see below). Two-hybrid assays were carried out using the
strain Y704 (MAT
 
a
 
 lexAop-LEU2 lex-Aop-lacZ sst1
 
D
 
 his3 trp1 ura3-52
leu2
 
). The effect of verprolin deletion on Myo5p localization was evalu-
ated in the 
 
vrp1
 
D
 
 strain (GVY1 - MAT
 
a
 
/MAT
 
a
 
 leu2-3,112/leu2-3,112
ade1/ade1 ura3-52/ura3-52 Ile-/Ile- MEL1/MEL1 vrp1::LEU2/rrp1::
LEU2
 
) and the corresponding wild-type strain (Sc467-MAT
 
a
 
/MAT
 
a
 
leu2-3,112/leu2-3,112 ade1/ade1 ura3-52/ura3-52 Ile-/Ile- MEL1/MEL1).
 
Yeast manipulations including cell culture, transformation, and tetrad
analysis were carried out according to Guthrie and Fink (1991). Bacterial
manipulations were carried out according to Sambrook et al. (1989).
 
Construction of Plasmids Containing Mutant
myo5 Constructs
 
Expression vectors for these studies will be referred to using the following
convention: (
 
a
 
) p
 
MYO5, 
 
plasmid-borne wild-type 
 
MYO5
 
 gene bearing
three copies of the myc epitope at its carboxy terminus; (
 
b
 
) pTH2
 
D
 
, plas-
mid-borne myc-tagged 
 
MYO5
 
 gene bearing a deletion of the TH2 region;
(
 
c
 
) pSH3
 
D
 
, plasmid-borne myc-tagged 
 
MYO5
 
 gene bearing a deletion of
the SH3 region; (
 
d
 
) pTH2
 
D
 
–SH3
 
D
 
, plasmid-borne myc-tagged 
 
MYO5
 
gene bearing deletions of the TH2 and SH3 regions; and (
 
e
 
) pSH3, plas-
mid-borne myc-tagged SH3 domain of the 
 
MYO5
 
 gene.
All 
 
myo5
 
 containing plasmids used in this study were generated using
 
1.
 
Abbreviations used in this paper
 
: aa, amino acids; HA, hemagglutinin;
LAT-A, latrunculin-A; RT, room temperature; SH3, src homology do-
main 3; TH1, tail homology domain 1; TH2, tail homology domain 2;
YPD, rich, glucose-based media. 
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the pRS-Y2 
 
MYO5
 
-myc construct described in our previous work (Good-
son et al., 1996). pTH2
 
D
 
 was created using the Transformer Site-Directed
Mutagenesis Kit from Clontech Laboratories, Inc. (Palo Alto, CA) ac-
cording to the manufacturer’s protocol. The selection oligonucleotide
primer used for this construct (5
 
9
 
-GCGGTGGCGGTCGCTCTAGAAC-
3
 
9
 
) destroys a unique NotI site in the noncoding region of the vector. The
mutagenic primer used was 5
 
9
 
GCAGCCCAGCATGTTAAAGAACC-
CATGTTGAAGC-3
 
9
 
. The pSH3
 
D
 
 and pTH2
 
D
 
–SH3
 
D
 
 constructs were
created using overlapping PCR products with site-directed mutations. For
pSH3
 
D
 
 and pTH2
 
D
 
–SH3
 
D
 
 constructs, the outer primers used were 5
 
9
 
-
CTCGAGGTCGACGGTATCGA-3
 
9
 
 and 5
 
9
 
-CAATATCAGTTCGTC-
GTGG-3
 
9
 
. The inner primers were 5
 
9
 
-CCAAAAGAACCCATGTT-
TGAAAAACCACATTCCGGAAATAATAATATC-3
 
9
 
 and 5
 
9
 
-GATA-
TTATTATTTCCGGAATGTGGTTTTTCAAACATGGGTTCTTT-
TGG-3
 
9
 
 for pSH3
 
D
 
 and 5
 
9
 
-GCTGCAGCCCAGCATGTTAAACCA-
CATTCCGGAAATAATAATATC-3
 
9
 
 and 5
 
9
 
-GATATTATTATTTCCGG-
AATGTGGTTTAACATGCTGGGCTGCAGC-3
 
9
 
 for pTH2
 
D
 
–SH3
 
D
 
. The
full-length PCR products from the pSH3
 
D
 
 and pTH2
 
D
 
–SH3
 
D
 
 mutations
were cloned in place of the endogenous BstEII–SalI fragment of pRS-Y2
 
MYO5
 
-myc.
The plasmid containing the SH3 domain of 
 
MYO5
 
 (pSH3) was con-
structed by PCR using the primers 5
 
9
 
-TTATGTGGCCAATACG-
AATTTAACCGCTTTATAGAAATGGCTATCCCAAAAGAACCCA-
TGTTTGAAGCGGCTTACG-3
 
9
 
 and 5
 
9
 
-GACCATGATTACGCCAAG-
CTC-3
 
9
 
. The PCR product was digested with MscI and XhoI and cloned in
place of the endogenous MscI–XhoI fragment of pRS-Y2 
 
MYO5
 
-myc. All
constructs were confirmed by DNA sequencing.
 
Construction of Plasmids for Two-Hybrid Analysis
 
To create p1360, carrying a DNA fragment coding for Vrp1p (1–200), we
amplified a 0.6-kb fragment of 
 
VRP1
 
 by PCR with primers (5
 
9
 
-GGATC-
CAAATGGCAGGTGCTCCAGCTCCT-39) and (59-GCGGCCGCTCA-
CCTTACTGAAGGCATATGCGG-39) that incorporated BamHI and
NotI sites. The product was ligated into pCR-Script/SK1 (Stratagene, La
Jolla, CA). To create p1361, carrying a DNA fragment coding for Vrp1p
(195–817), we amplified a 1.9-kb fragment of VRP1 by PCR with primers
(59-GGATCCATATGCCTTCAGTAAGGCCAGCAC-39) and (59-GCG-
GCCGCTCACGTAAATAATGTTAAGTCCAATGGCACACTACT-
AC-39) that incorporated BamHI and NotI sites. The product was ligated
into pCR-Script/SK1 (Stratagene, La Jolla, CA).
To create p1645, carrying a DNA fragment coding for Myo3p (1,118–1,271),
we amplified a 0.5-kb fragment of MYO3 by PCR with primers (59-CAA-
CCAAAGGATCCGAAATTCGAAGCT-39) and (59-TCGCGACCAGT-
CATCATCATC ATCGCCATCGT-39) that used an internal BamHI site
in the MYO3 sequence and incorporated an NruI site before the stop
codon of the MYO3 sequence, and then the product was ligated into pCR
2.1 TOPO (Invitrogen, Carlsbad, CA). p1686 is similar to p1645 except
that the NruI site is replaced by a stop codon followed by a NotI site.
p1705 contains a BamHI to NotI fragment encoding for Myo3p (1,118–
1,271) cloned into KS1 (Stratagene). To create p1408, carrying a DNA
fragment coding for Myo5p (1,082–1,219), we amplified a 0.4-kb fragment
of  MYO5 by PCR with primers (59-TGGATCCGCGAATCAAAGC-
CAAAAGAACCCATGTTTGAAG-39) and (59-TGCGGCCGCTGAT-
TACCAATCATCTTCCTCTTCATCT-39) that incorporated BamHI
and NotI sites and then the product was ligated into pCR-Script/SK1.
Two-hybrid constructs were based on pEG202 (Gyuris et al., 1991),
which encodes the LexA DNA-binding domain, pJG4-5 (Gyuris et al.,
1991), which encodes the B42 transcription activation domain, and pACT
(Durfee et al., 1993), which encodes the Gal4p transcription activation do-
main. pEG202-derived plasmids used were p1386, which contains a
BamHI to NotI fragment encoding Vrp1p (1–200); p1388, which contains
a BamHI to NotI fragment encoding Vrp1p (195–817); p1707, which con-
tains a BamHI to NotI fragment encoding Myo3p (1,118–1,271); and
p1456, which contains a BamHI to NotI fragment encoding Myo5p
(1,082–1,219). pJG4-5–derived plasmids used were p1387, which contains
a BamHI to NotI fragment encoding Vrp1p (1–200); p1389, which con-
tains a BamHI to NotI fragment encoding Vrp1p (195–817); p1706, which
contains a BamHI to NotI fragment encoding Myo3p (1,118–1,271);
p1457, which contains a BamHI to NotI fragment encoding Myo5p
(1,082–1,219). p1962 is a pACT-derived plasmid that encodes full-length
Vrp1p (Vaduva et al., 1997).
Epitope Tagging of Vrp1p
Vrp1p was tagged at its carboxy terminus with three copies of the peptide
epitope from the HA protein of human influenza virus using a derivative
of a gene disruption cassette (Wach, 1996; Longtine et al., 1998). This cas-
sette codes for three copies of the HA epitope and the heterologous dom-
inant resistance marker, kanMX, which confers geneticin (G418) resis-
tance in yeast. The cassette with long-flanking VRP1 homology regions
was produced using PCR amplification and the forward and reverse prim-
ers: 59-AAAGGGTAGTAGTGTGCCATTGGACTTAACATTATTTA-
CGCGGATCCCCGGGTTAATTAA-39 and 59-TGTTCTTCAGTGAT-
TTATTGTAACCATGGAGAAATGCTCAGAATTCGAGCTCGTTT-
AAAC-3. myo3D myo5D cells bearing pMYO5 were transformed with the
PCR product. Cells bearing the integrated cassette were selected by
growth on rich, glucose-based media (YPD) plates containing 200 mg/liter
of G418 (Sigma Chemical Co., St. Louis, MO). HA tagging of Vrp1p was
confirmed by Western blot analysis using an anti-HA antibody (clone
3F10; Boehringer Mannheim, Indianapolis, IN). HA-tagged Vrp1p is a 93-
kD protein based on its amino acid content. However, HA-Vrp1p mi-
grates on SDS gels as a 120-kD protein, presumably due to its high proline
content.
Light Microscopy
Actin cytoskeletal structure and chitin deposition were visualized using
rhodamine–phalloidin, a rabbit polyclonal antibody raised against yeast
actin (Drubin et al., 1988), and calcofluor (Sigma Chemical Co.) according
to published procedures (Adams et al., 1991; Pringle et al., 1991). Immuno-
fluorescence detection of myc-tagged Myo5p was carried out as described
previously (Goodson et al., 1996). HA-tagged Vrp1p was visualized using
a rat monoclonal antibody (see above), and FITC-coupled goat anti–rat
antibody (Kirkegaard and Perry Laboratories, Inc., Gaithersburg, MD).
Other methods (fixation, mounting, and DAPI staining) were as described
by Pringle et al. (1991). Photomicroscopy was performed on a Leitz Di-
alux microscope (Rockleigh, NJ) and a Zeiss Axioplan II microscope
(Oberkochen, Germany). Images were collected using a cooled charge-
coupled device camera (model Star-1; Photometrics, Tucson, AZ). Light
output from the 100-W mercury arc lamp was controlled using a shutter
driver (model Uniblitz D122; Vincent Associates, Rochester, NY) and at-
tenuated using neutral density filters (Omega Optical Corporation, Brat-
tleboro, VT). Image enhancement and analysis were performed on a Mac-
intosh Quadra 800 computer (Cupertino, CA) using the public domain
program NIH Image 1.60 (National Institutes of Health, Bethesda, MD).
Images were stored on a magnetic optical disk drive (Peripheral Land
Inc., Fremont, CA).
Electron Microscopy
Preparation of samples for transmission electron microscopy was carried
out according to Stevens (1977). Yeast were fixed by addition of glutaral-
dehyde (Sigma Chemical Co.) to growth medium to a final concentration
of 5%. After incubation for 3 h at room temperature (RT), cells were con-
centrated by centrifugation at 10,000 g for 10 min at RT and then washed
two times with 0.9% NaCl. Samples were resuspended in 4% KMnO4 in
0.1 M Na-cacodylate, pH 7.4 (Electron Microscopy Sciences, Fort Wash-
ington, PA), and incubated at 48C for 1 h with gentle rotation. After two
washes with 0.9% NaCl, samples were resuspended in 2% uranyl acetate
(Electron Microscopy Sciences) and then incubated for 1 h at RT. Sam-
ples were washed three times, dehydrated in a graded series of ethanol so-
lutions, infiltrated with propylene oxide for 10 min, and then embedded in
Epon-812 (Tousimis Research Co., Rockville, MD). Ultrathin sections
were stained for 5 min with 1% lead citrate before viewing with a JEOL
1200 transmission electron microscope (Peabody, MA).
Immunoprecipitation
50-ml cultures of various yeast strains were grown to mid-log phase. Cells
were collected and lysed by vortexing for 6 min at 48C with 0.5-mm glass
beads in a solution consisting of 10% glycerol, 10 mM EGTA, 1% Triton
X-100, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM ATP,
2 mM PMSF, and protease inhibitor cocktail as described in Lazzarino et al.
(1994). The protein extracts were clarified by centrifugation for 5 min at
10,000 g and the supernatant was used for immunoprecipitation experi-
ments. 200 ml of 2 mg/ml protein extract were incubated with 6 mg of anti-
myc antibody for 2 h at 48C. Thereafter, 15 ml of protein–G Sepharose 4
Fast Flow (Pharmacia Biotech. Inc., Piscataway, NJ) pretreated with BSA
was added. This mixture was further incubated for 1 h at 48C. The
Sepharose beads were then pelleted and washed two times with a buffer
consisting of 20 mM Tris-HCl, pH 7.5, 10% glycerol, 1% Triton X-100,The Journal of Cell Biology, Volume 141, 1998 1360
150 mM NaCl, 1 mM PMSF, and protease inhibitor cocktail. Proteins re-
covered on Sepharose beads were separated by SDS-PAGE (Laemmli,
1970) and analyzed by immunoblots (Towbin et al., 1979).
Other Methods
To detect mutant and wild-type Myo5p protein expression levels, whole
cell extracts were prepared by vortexing yeast cells with 0.5-mm glass
beads in a solution consisting of 10% glycerol, 10 mM EGTA, 1% Triton
X-100, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM PMSF, and protease
inhibitor cocktail. Protein concentrations were determined using the
bicinchoninic acid assay following the vendor's protocol (Pierce Chemical
Co., Rockford, IL). Gel electrophoresis and immunoblots were performed
as described above. Latrunculin-A (Molecular Probes, Eugene OR) treat-
ment was carried out as described in Ayscough et al. (1997).
Results
Construction and Expression of myo5 Mutants
Expression of myc-tagged Myo5p on a low-copy number
plasmid under control of the MYO5 promoter (pMYO5)
complements slow growth rate and defects in actin organi-
zation and function produced by deletion of endogenous
myosin I genes (Goodson et al., 1996). To investigate the
functional roles of various domains within the tail of
Myo5p, we created MYO5–myc constructs containing de-
letions of either the TH2, SH3, or TH2 and SH3 domains
(Fig. 1). We defined the TH2 domain as amino acids (aa)
1,000–1,091, a region enriched in glycine, proline, and ala-
nine that is amino-terminal to the SH3 domain. However,
in some Acanthamoeba and Dictyostelium myosin I pro-
teins, the TH2 region is believed to be bipartite: part of the
TH2 region is amino-terminal to the SH3 domain, and part
is carboxy-terminal to the SH3 domain. Since a proline-
and alanine-rich region is present carboxy-terminal to the
SH3 domain in Myo5p (aa 1,141–1,200), it is formally pos-
sible that the TH2 region of yeast myosin I proteins ex-
tends beyond the region deleted in this study. The SH3 do-
main of MYO5 encompasses aa 1,092–1,140. We expressed
these mutant myosin I constructs using low-copy, cen-
tromere-based plasmids and the endogenous MYO5 pro-
moter in cells bearing deletions of endogenous myosin I
genes, and then examined the effect of mutant myosin I
proteins on actin organization and function in vivo.
Expression of various epitope-tagged and untagged
Myo5p in myo3D myo5D mutants was examined by West-
ern blot analysis using an anti-myc antibody (Evan et al.,
1985) and an antibody raised against a myosin I–specific
peptide (Ruppert et al., 1993) (Fig. 2). Western blot analy-
sis using a myosin I–specific antipeptide antibody indicated
that the level of expression of plasmid-borne wild-type
and mutant Myo5p in the myo3D myo5D cells is similar to
that of endogenously expressed myosin I proteins in wild-
type cells. Moreover, myc-tagged myosin I proteins of the
expected electrophoretic mobility were detected in cells
expressing wild-type and mutant MYO5 genes. The level
of expression of Myo5p bearing deletions in both SH3 and
TH2 domains is lower than that of wild-type Myo5p. How-
ever, the level of the other mutant proteins was compara-
ble to that of protein expressed from pMYO5.
Effect of Mutant myo5 Constructs on Cell Growth
Deletion of MYO3 and MYO5 results in severe growth de-
fects. The doubling time of the myosin I double deletion
mutant in liquid culture at 308C is two to three times
greater than that of wild-type cells or myosin I single mu-
tants (Goodson et al., 1996). In addition, myo3D myo5D
cells do not grow on solid rich media at 378C or at high os-
motic strength (0.75 M KCl) (Goodson et al., 1996). Ex-
pression of pMYO5 in myo3D myo5D cells fully restores
growth under all of the restrictive conditions (Goodson et al.,
1996; Fig. 3 and Table I).
The growth of pTH2D-expressing cells is indistinguish-
able from that of wild-type cells or of pMYO5-rescued my-
osin double mutants (Fig. 3 and Table I). In contrast, dele-
tion of the SH3 domain from MYO5 results in defects in
Myo5p function (Fig. 3 and Table I). Although pSH3D-
expressing cells grow under all conditions tested, the ex-
tent of growth on solid medium at 378C or at high osmotic
strength, and the rate of growth in liquid culture are signif-
icantly lower than those of wild-type cells or myo3D myo5D
cells rescued with pMYO5. Unlike the myo3D myo5D cells,
which exhibit a large increase in doubling time after tem-
perature shift to 378C, the pSH3D-expressing cells grow at
378C as efficiently as at 308C (Table I). Although deletion
of the TH2 domain of Myo5p does not have any significant
effect on growth, deletion of both the TH2 and SH3 do-
mains produces a growth rate slightly lower than that ob-
served after deletion of the SH3 domain alone (Fig. 3 and
Figure 1. Schematic diagram of Myo5p mutants. pMYO5, plas-
mid-borne wild-type MYO5 gene bearing three copies of the myc
epitope at its carboxy terminus; pTH2D, plasmid-borne, myc-
tagged  MYO5 gene bearing a deletion of the TH2 region; pSH3D,
plasmid-borne, myc-tagged MYO5 gene bearing a deletion of the
SH3 region; pTH2D-SH3D, plasmid-borne, myc-tagged MYO5
gene bearing deletions of the TH2 and SH3 regions; pSH3, plas-
mid-borne, myc-tagged SH3 domain of MYO5 gene. With the ex-
ception of pSH3, all constructs were expressed in myo3D myo5D
mutant cells. pSH3 was expressed in the myo3D strain. All pro-
teins were expressed under control of the MYO5 promoter.
Figure 2. Expression of myc-
tagged  myo5 mutant pro-
teins.  Western blot of whole
cell protein extracts (200 mg/
lane) from wild-type (lane
A), myo3D myo5D mutants
containing empty vector
(lane  B), pMYO5 (lane C),
pTH2D (lane D), pSH3D
(lane  E), and pTH2D-SH3D
(lane F). The blot was probed using 9E10 anti-myc antibody
(panel  A) and myosin I protein-specific antibody G371 (panel B).Anderson et al. Myosin I Function and Localization in Yeast 1361
Table I). We attribute this decrease in growth rate to the
fact that the expression level of mutant Myo5p bearing
both TH2 and SH3 deletions is somewhat lower than that
of all other expression constructs.
Effect of Mutant myo5 on
Repolarization of the Actin Cytoskeleton after 
Temperature-induced Depolarization
Actin patches and cables are the two F-actin–containing
structures detected by light microscopy in budding yeast.
In wild-type yeast, patches are concentrated exclusively in
buds and cables are aligned along the mother–bud axis
(Kilmartin and Adams, 1984). This polarization of actin
cytoskeletal structures is transiently disrupted by tempera-
ture shift. Transfer of wild-type yeast cultures from 308 to
378C for 30 min causes loss of actin cables and delocaliza-
tion of actin patches over both mother and bud cell sur-
faces. Polarization of actin cables and patches is restored
within 90 min after the temperature shift (Lillie and
Brown, 1994; Fig. 4 A, panels A, D, and G).
Actin patches and cables are present in myo3D myo5D
mutants. However, deletion of yeast myosin I genes results
in loss of actin polarization in over 95% of the cells exam-
ined during vegetative growth at 308C (Goodson et al.,
1996; Fig. 5). This depolarization persists through the tem-
perature shift (Fig. 4 A, panels B, E, and H). Expression of
pMYO5 in these cells restores organization of the actin cy-
toskeleton during vegetative growth at 308C (Goodson et al.,
1996), and the normal time course of actin repolarization
after temperature-induced depolarization (Fig. 4 A, panels
C, F, and I).
We examined the actin polarization and time course of
actin repolarization in response to temperature shift in
pTH2D-, pSH3D- and pTH2D–SH3D-expressing cells (Figs.
4 and 5). Actin organization during growth at 308C, and
the kinetics of actin repolarization after shift to 378C, are
not significantly altered in pTH2D-expressing cells com-
pared with double deletion mutants expressing pMYO5
(Fig. 4 B, panels A, D, and G). In contrast, actin organiza-
tion during vegetative growth at 308C and the kinetics of
actin reorganization are altered in pSH3D- and pTH2D–
SH3D-expressing cells (Fig. 4 B, panels B, E, and H and C,
F, and I, respectively). Depolarization of actin is observed
in 20–30% of pSH3D- or pTH2D–SH3D-expressing cells
even at 308C (Fig. 5). Moreover, only 44–48% of these cells
display repolarization of the actin cytoskeleton 90 min after
temperature shift. For comparison, z85% of the cells ex-
pressing pMYO5 or pTH2D display actin repolarization
under similar conditions. Therefore, the SH3 domain of
Myo5p is required for full Myo5p function in actin organi-
zation.
Effect of Mutant myo5 on Actin-dependent Activities
Phenotypic analysis of yeast bearing mutations in actin
(ACT1) or in the actin-binding proteins fimbrin (SAC6),
capping protein (CAP1, 2), profilin (PFY1), conventional
myosin (MYO1), and myosin V (MYO2) suggest a role for
the actin cytoskeleton in control of cell shape, bud site se-
lection, secretion, endocytosis, cell wall and chitin deposi-
tion, growth at high osmotic strength, and mitochondrial
organization (Novick and Botstein, 1985; Haarer et al.,
1990; Rodriguez and Patterson, 1990; Adams et al., 1991;
Johnston et al., 1991; Amatruda et al., 1992; Chowdhury
et al., 1992; Liu and Bretscher, 1992; Drubin et al., 1993;
Kübler and Riezman, 1993; Lazzarino et al., 1994; Simon
et al., 1995). To determine whether the defects in actin
structure observed in cells expressing myo5 mutations also
produce defects in actin-dependent functions, we studied
the effect of myo5 mutations on mitochondrial, nuclear,
and vesicular organization and on chitin and cell wall dep-
osition (Table II).
Wild-type cells and myo3D myo5D mutants that express
Figure 3. Growth characteristics of myo3D,myo5D mutants ex-
pressing various myo5 constructs. Wild-type (row A), and myo3D
myo5D mutants containing empty vector (row B), pMYO5 (row
C), pTH2D (row D), pSH3D (row E), and pTH2D–SH3D (row F)
were grown on YPD–containing solid media at 308 or 378C, or in
YPD supplemented with 0.75 M KCl at 308C.
Table I. Doubling Times of myo3D myo5D Cultures Expressing 
Mutant myo5 Constructs
MYO5 construct
Doubling time
30°C 37°C
(min)
Wild-type (n 5 11) 94 6 6 97 6 5
myo3D myo5D 1 vector (n 5 11) 216 6 22 368 6 32 P , 0.001
myo3D myo5D 1 pMYO5 (n 5 11) 98 6 8 104 6 10
myo3D myo5D 1 pTH2D (n 5 11) 102 6 5 108 6 7
myo3D myo5D 1 pSH3D (n 5 10) 163 6 16 158 6 14 P , 0.001
myo3D myo5D 1 pTH2D-SH3D (n 5 10) 183 6 14 180 6 15 P , 0.001
Cultures of myo3D,myo5D mutant cells transformed with either wild-type or mutant
myc-tagged MYO5 on a centromeric plasmid (pRS-Y2) were grown to early log phase
in synthetic complete media lacking uracil at 30°C and at 37°C. Aliquots were re-
moved periodically from all cultures and the cells were sonicated briefly to disrupt
clumps. Cell densities were determined by OD600 measurements and apparent dou-
bling times were calculated. The P values demonstrate significance levels compared to
wild-type growth rates.The Journal of Cell Biology, Volume 141, 1998 1362
pMYO5, or pTH2D all display normal mitochondrial mor-
phology: mitochondria in these cells are extended, tubular
structures colocalizing with actin cables. These cells also
display normal cell walls, normal chitin rings at bud sites,
and no significant accumulation of intracellular membrane
or vesicle. In contrast, pSH3D- or pTH2D–SH3D-express-
ing cells display (a) mitochondrial aggregation; (b) accu-
mulation of small (50-nm) vesicles and large (200–500-nm
diam) multilamellar structures that resemble the Berkeley
bodies previously observed in late secretory mutants
(Novick et al., 1981); (c) abnormal, delocalized chitin dep-
osition over the surface of the mother cell, and abnormal,
brightly stained patches of chitin irregularly deposited in
the cell walls; and (d) thickened cell wall (Table II). The
defects in actin-dependent processes in pSH3D- and
pTH2D–SH3D-expressing cells are not as severe as those
in myosin I double deletion cells expressing vector alone.
Thus, the observed partial defects in actin organization de-
scribed above correlate with partial defects in actin function.
Effect of Actin Depolarization and Depolymerization 
on Myo5p
In wild-type cells grown at 308C, immunostaining of myc-
Figure 4. The organization
of the yeast actin cytoskele-
ton in myo3D myo5D cells
rescued with various MYO5
constructs. Wild-type cells
(A, panels A, D, and G),
myo3D myo5D cells carrying
empty vector (A, panels B, E,
and  H), p MYO5 ( A , panels
C, F, and I), pTH2D (B, pan-
els A, D, and G), pSH3D (B,
panels  B,  E, and H), or
pTH2D–SH3D (B, panels C,
F, and I) were fixed before
shift to 378C (A and B, panels
A, B, and C), 30 min after a
shift to 378C (A and B, panels
D, E, and F), and 90 min after
a shift to 378C (A and B, pan-
els G, H, and I). Cells were
converted to spheroplasts,
stained with rhodamine–
phalloidin, and then viewed
as described in Materials and
Methods. Bar, 1 mm.Anderson et al. Myosin I Function and Localization in Yeast 1363
tagged Myo5p reveals punctate staining and polarization,
i.e., enrichment in the bud at sites of polarized cell surface
growth (Fig. 6 B). Myo5p patches show cell cycle depen-
dent polarization that correlates with actin patch polariza-
tion. In cells bearing small- and medium-sized buds, actin
patches (Fig. 6 A) and Myo5p patches (Fig. 6 B) are en-
riched in the bud. There is a correlation between actin
patch depolarization and Myo5p depolarization in cells
bearing large buds (Table III). 30 min after the tempera-
ture shift, concomitant with loss of actin polarization (Fig.
6 C), Myo5p patch localization is clearly altered. At this
time point, Myo5p staining is still punctate; however,
Myo5p patches are delocalized throughout both mother
and daughter cells (Fig. 6 D). Finally, Myo5p patch repo-
larization occurs concomitant with repolarization of actin
patches; both are complete within 90 min after the temper-
ature shift (Fig. 6, E and F). This correlation between po-
larization of actin and Myo5p patches is consistent with a
role of Myo5p in actin organization.
To evaluate the role of F-actin depolymerization in
Myo5p patch assembly and polarization, we treated cells
with latrunculin-A (LAT-A; Spector et al., 1983; Ay-
scough et al., 1997). Treatment of myo3D myo5D cells ex-
pressing pMYO5 with LAT-A for 15 min causes complete
loss of F-actin as assessed by rhodamine–phalloidin stain-
ing (Fig. 7, B and D). This treatment also causes a signifi-
cant decrease in the intensity of Myo5p staining in patches,
suggesting a defect in Myo5p patch assembly or stabiliza-
tion. In addition, Myo5p patches which are present in
LAT-A–treated cells show depolarization (Fig. 7, A and
C). Over 90% of control cells treated with the same con-
centration of DMSO as that used for LAT-A treatment
display enrichment of Myo5p patches in the bud of cells
bearing small- and medium-sized buds. In contrast, only
12.5% of the LAT-A–treated cells examined display po-
larized Myo5p patches in cells bearing small- and medium-
sized buds. Although polarization of Myo5p was observed
in some LAT-A–treated cells, the level of enrichment of
Myo5p in buds of LAT-A–treated cells was not as great as
that observed in controls.
The SH3 Domain of Myo5p Is Required but
Not Sufficient for Localization of Myo5p at Sites of 
Polarized Cell Surface Growth
To determine whether the TH2, SH3, or both domains
have a role in Myo5p targeting, we examined the localiza-
tion of proteins expressed from pMYO5, pTH2D, pSH3D,
and pTH2D–SH3D by indirect immunofluorescence (Fig.
8). In all cases, staining of wild-type and mutant Myo5p
was punctate and cortical (Fig. 8, B, D, F, and H). More-
over, patches containing TH2-deleted Myo5p resembled
Figure 5. Actin cytoskeletal polarization and re-
polarization after shift to 378C are defective in
pSH3D- or pTH2D–SH3D-expressing cells. Wild-
type cells (A), myo3D myo5D cells carrying empty
vector (B) and pMYO5 (C), pTH2D (D), pSH3D
(E), or pTH2D-SH3D ( F ) were removed from
liquid culture at the indicated times after shift to
378C, fixed, converted to spheroplasts, and then
stained with rhodamine–phalloidin. Cells were
scored as having a depolarized actin cytoskeleton
if they contained more than six actin patches
within the mother cell. The graphs indicate the
percentage of cells that retained polarization of
the actin cytoskeleton. These percentages are the
average of values from three experiments. n .
100 for each experiment.
Table II. Effect of MYO5 Mutations on Actin Function
Strain
% of cells displaying
Mitochondrial aggregation Cell wall thickening Membrane accumulation Multinucleation Chitin patches
Wild-type ,300 0 0
myo3D myo5D 1 vector 21 34 61 58 60
myo3D myo5D 1 pMYO5 ,300 0 0
myo3D myo5D 1 pTH2D, 30 , 20 0
myo3D myo5D 1 pSH3D 15 15 19 18 17
myo3D myo5D 1 pTH2D-SH3D 15 11 19 11 15
Mitochondria organization and multinucleation were determined in mid-log phase cells after fixation, staining of nuclear and mitochondrial DNA using the DNA-binding dye 49,6-
diamidino-2-phenylindole, and visualization by fluorescence microscopy as described previously (Goodson et al., 1996). Cell wall thickening and intracellular accumulation were
visualized by transmission electron microscopy, as described previously (Goodson et al., 1996). In all cases, measurements were performed on fields of randomly selected cells.
Chitin deposition was examined using calcofluor white staining and fluorescence microscopy (Goodson et al., 1996). The number of cells examined for each sample was 67–288.The Journal of Cell Biology, Volume 141, 1998 1364
wild-type Myo5p patches and were enriched in the bud
(n 5 74). In contrast, patches containing Myo5p bearing
deletions in the SH3 domain alone, or in the TH2 and SH3
domains, were evenly distributed in mother cells and bud:
only 3% of cells examined showed enrichment of these
proteins in the bud (n 5 101 and n 5 111, respectively; Fig.
8, F and H). Although partial depolarization of the actin
cytoskeleton is observed in pSH3D- and pTH2D–SH3D-
expressing cells, depolarization of Myo5p patches in these
cells is not due to effects on actin organization. Patches con-
taining mutant Myo5p protein are delocalized even in
pSH3D- and pTH2D–SH3D-expressing cells that contain
polarized actin patches and cables.
According to the results described above, the SH3 do-
main is required for targeting of Myo5p to growing buds.
To examine the role of this domain in (a) assembly of
Myo5p into patches, and (b) enrichment of Myo5p patches
at sites of polarized cell surface growth, we constructed a
plasmid, pSH3, carrying the SH3 domain and the subse-
quent 79-aa carboxy terminus of Myo5p (aa 1,086–1,219)
fused to three copies of the myc epitope. This construct
was expressed and localized in a MYO3 deletion mutant.
myo3D cells were used for expression because they con-
tain a polarized actin cytoskeleton, and only one of two
endogenous myosin I genes. Western blot analysis using
the anti-myc antibody indicates that expression of pSH3
using a low-copy plasmid and the endogenous MYO5 pro-
moter produces a protein of the expected apparent molec-
ular weight at levels comparable to that of protein expressed
from pMYO5 (data not shown). Immunolocalization of
this fusion protein using the anti-myc antibody reveals dif-
fuse staining which is distributed throughout the cyto-
plasm (Fig. 9). Thus, the SH3 domain of Myo5p is not suf-
ficient for either association of Myo5p with patches or for
enrichment of Myo5p patches at sites of polarized cell sur-
face growth.
The Proline-rich, SH3-binding Protein, Verprolin, Is a 
Myo5p Binding Partner
In two-hybrid tests for protein–protein interaction, the
Figure 6. Loss of actin patch polarity and Myo5p localization co-
incide after a shift to 378C. myo3D myo5D cells expressing
pMYO5 were grown to mid-log phase at 308C (A and B) and
shifted to 378C. After 30 (C and D) or 90 min (E and F) of incu-
bation, aliquots were removed, fixed, and then converted to
spheroplasts. In this double-label experiment, actin (A, C, and E)
and myc-tagged Myo5p (B, D, and F) were visualized as de-
scribed above. Asymmetric Myo5p localization and actin patch
polarization are lost after incubation at 378C for 30 min (C and
D) and restored after 90 min of incubation at 378C (E and F).
Bar, 1 mm.
Table III. Myo5p Polarized Localization Is Coincident with 
Actin Polarization
Strain Bud size
% of cells with
Polarized
actin patches
Polarized
Myo5p patches
myo3D myo5D 1 pMYO5 Small 100 95 (n 5 392)
Large 1 1.5 (n 5 135)
myo3D 1 pMYO5 Small 98 95 (n 5 318)
Large 2 0 (n 5 131)
Cultures of myo3D myo5D or myo3D mutant cells transformed with pMYO5 were
grown to midlog phase. Cells were fixed and converted to spheroplasts and stained for
actin and myc as described above. Cells were considered to be small-budded if their
bud length was #1/3 of the length of the mother cell, and large budded if their bud
length was .1/3 of the length of the mother cell. The actin cytoskeleton was scored as
polarized, if the bud showed a significant concentration of actin patches with no more
than five patches in the mother. Myo5p patches were scored as polarized if the bud
showed a significant concentration of Myo5p patches. (n 5 number of cells observed).
Figure 7. Localization of Myo5p in LAT-A treated cells. myo3D
myo5D cells expressing pMYO5 were grown to mid-log phase at
308C. Aliquots were then removed and the cells were treated with
0.15 mM LAT-A dissolved in DMSO (C and D) or with equal
volume of DMSO (A and B). After 15 min of incubation at 308C
cells were fixed, converted to spheroplasts, and then double la-
beled with anti-myc antibody (A and C) and rhodamine–phalloidin
(B and D). Asymmetric Myo5p localization is lost in LAT-A–
treated cells. Bar, 1 mm.Anderson et al. Myosin I Function and Localization in Yeast 1365
SH3 domains of Myo3p and Myo5p bound a 10-residue
polyproline sequence (Evangelista, M., and C. Boone, un-
published data). With a short polyproline sequence as a
probe, we performed a BLAST search (Altschul et al.,
1990) against the translated yeast genome to identify po-
tential binding partners for the SH3 domain of yeast myo-
sin I proteins. This search highlighted verprolin, Vrp1p, an
actin-binding protein implicated in actin cytoskeletal orga-
nization and function (Donnelly et al., 1993; Vaduva et al.,
1997). Vrp1p contains several short stretches of polypro-
line and 11 copies of a potential SH3-binding motif with
the general sequence APPL/IP (Bar-Sagi et al., 1993). We
therefore evaluated interactions between Vrp1p and the
SH3 domain of yeast type I myosins using the two-hybrid
system (Table IV). We find that both the Myo3p and
Myo5p SH3 domains interact with full-length Vrp1p and
with two smaller Vrp1p fragments, Vrp1p (1–200) and Vrp1p
(195–817). Thus, the SH3 domains of the yeast myosin I
proteins may bind to multiple sites within Vrp1p.
If Vrp1p and Myo5p interact in vivo, then these two pro-
teins should colocalize. Localization of Vrp1p was per-
formed by tagging the chromosomal copy of the VRP1
gene at its carboxy terminus with three copies of the HA
epitope. We find that carboxy-terminal tagging has no ef-
fect on Vrp1p function; growth rates (data not shown) and
actin cytoskeletal organization (Fig. 10 B) of the HA-
Vrp1p expressing cells are indistinguishable from those of
cells expressing untagged Vrp1p. This observation is con-
sistent with the report that addition of GFP to the car-
boxy-terminus of Vrp1p does not affect Vrp1p function
(Vaduva et al., 1997). Visualization of HA-tagged Vrp1p
confirmed the observation that Vrp1p is localized to punc-
tate structures enriched at sites of polarized cell surface
growth (Vaduva et al., 1997). In addition, we find that
Myo5p patches colocalize with Vrp1p patches (Fig. 10, C
and D).
Consistent with this, we find that Vrp1p is required for
polarization of both Myo5p patches and the actin cytoskel-
eton. A vrp1D strain and the corresponding wild-type par-
ent which express myc-Myo5p were fixed and stained for
Myo5p and the actin cytoskeleton. As described previ-
ously, VRP1 deletion causes actin cytoskeletal depolariza-
tion (Vaduva et al., 1997). Our studies confirm this obser-
vation, and show that Myo5p patches are polarized in the
wild-type strain (Fig. 10, E and F) and depolarized in the
vrp1D cell (Fig. 10, G and H).
Finally, to test for direct interactions between Vrp1p
and Myo5p in yeast, myc-tagged Myo5p was immunopre-
cipitated from extracts of cells that express myc-tagged
Figure 8. Localization of wild-type and mutant MYO5 gene
products. Mid-log phase myo3D myo5D cells expressing pMYO5
(A and B), pTH2D (C and D), pSH3D (E and F), or pTH2D–
SH3D (G and H) were fixed, converted to spheroplasts, and then
stained for actin (A, C, E, and G) and myc (B, D, F, and H) as de-
scribed above. The asymmetric localization of wild-type Myo5p
patches in the bud is lost after deletion of the SH3 or TH2 and
SH3 domains, but not after deletion of the TH2 domain alone.
Arrows point to examples of colocalization of Myo5p patches
with actin patches. Bar, 1 mm.
Figure 9. Localization of the SH3 domain of Myo5p. Mid-log
phase myo3D cells expressing pMYO5 (A and B) or pSH3, the
myc-tagged SH3 domain of Myo5p, (C and D) were fixed, con-
verted to spheroplasts, and then stained for actin (A and C) and
myc (B and D) as described above. The SH3 domain of Myo5p
does not show the same localization as full-length Myo5p. Bar, 1 mm.The Journal of Cell Biology, Volume 141, 1998 1366
Myo5p and HA-tagged Vrp1p. The immunoprecipitates
were analyzed by Western immunoblotting using probes
for myc and HA (Fig. 11). These reveal that Vrp1p coim-
munoprecipitates with Myo5p. This coimmunoprecipita-
tion is specific; it occurs only in cells that express both
tagged constructs, and is antibody dependent. Our find-
ings that Vrp1p (a) has the capacity to bind to the SH3 do-
main of Myo5p, (b) colocalizes with Myo5p, (c) is required
for polarization of both Myo5p patches and the actin cy-
toskeleton, and (d) coimmunoprecipitates with Myo5p
support a role for Vrp1p as a Myo5p binding partner.
Discussion
Type I myosin proteins have been identified in every eu-
karyotic cell studied. However, we are only beginning to
understand the roles of these proteins in actin-dependent
processes. In the budding yeast Saccharomyces cerevisiae,
we have evidence that a primary function of classic type I
myosins is the control of actin cytoskeletal organization
(Goodson et al., 1996). Consistent with this, we observe a
correlation between polarization of the actin cytoskeleton
and that of Myo5p patches. Incubation of yeast cells at
378C produces transient depolarization of both the actin
cytoskeleton and Myo5p patches. Moreover, subsequent
repolarization of the actin cytoskeleton occurs concomi-
tant with Myo5p patch repolarization.
In the present study, we also examined the role of myo-
sin I tail domains in the physiological function of the pro-
tein. To do so, we expressed mutated forms of the yeast
type I myosin MYO5 in myo3D myo5D cells and examined
the extent to which these mutant myosins can rescue wild-
type phenotypes. From this, we have drawn additional
conclusions concerning the nature of type I myosin func-
tion, and the role of tail domains in myosin I complex as-
sembly and targeting.
In vitro data suggest that classic myosin I proteins have
the capacity to bind and cross-link actin using the ATP-
insensitive actin binding site in the TH2 domain of their
tail and the ATP-sensitive actin binding site in their head,
and may therefore organize microfilament networks by
translocating actin structures in relation to other actin fila-
ments (refer to Introduction). However, we find that a
mutant Myo5p containing a deletion of the putative ATP-
insensitive actin binding site in the TH2 domain is fully
functional under the experimental conditions tested: growth
rates, actin organization and repolarization subsequent to
temperature shift, and actin-dependent processes includ-
ing mitochondrial organization, chitin deposition, cell
Table IV. Two-hybrid Interactions between Verprolin and the 
SH3 Domains of Myo3p and Myo5p
DNA-binding domain fusion Activation domain fusion lacZ activity
(Miller units)
Vrp1p (1–200) Vector 0.2 6 0.0
Myo3p (1,118–1,271) 1606.8 6 263.8
Myo5p (1,082–1,219) 1056.0 6 149.2
Vrp1p (195–817) Vector 0.3 6 0.2
Myo3p (1,118–1,271) 96.3 6 21.8
Myo5p (1,082–1,219) 345.1 6 7.3
Myo3p (1,118–1,271) Vector 0.5 6 0.1
Vrp1p (1–200) 253.8 6 27.1
Vrp1p (195–817) 74.5 6 4.3
Vrp1p (1–817) 7.3 6 0.4
Myo5p (1,082–1,219) Vector 0.3 6 0.0
Vrp1p (1–200) 140.3 6 2.3
Vrp1p (195–817) 28.5 6 2.0
Vrp1p (1–817) 22.1 6 0.8
Assays were done as described previously (Phizicky and Fields, 1995) using the
strain Y704; pJG4-5 was the vector control. Assays involving Vrp1p (1–817) trans-
formants were carried out in strain Y1003, a diploid W303 derivative carrying URA3:
:lexAop-lacZ/URA3::lexAop-ADE2 reporters. The lacZ activity associated with the
vector control in Y1003 was indistinguishable from that of Y704.
Figure 10. Myo5p colocalizes with Vrp1p and mislocalizes in a
vrp1 deletion mutant. myo3D myo5D cells expressing HA-Vrp1p
and Myc-Myo5p (A–D), were grown to mid-log phase, fixed, con-
verted to spheroplasts, and then stained for HA-tagged Vrp1p (A
and C), actin (B), and myc-tagged Myo5p (D). Arrows point to
examples of Myo5p andVrp1p colocalization. To evaluate the ef-
fect of VRP1 deletion on Myo5p localization, a vrp1D mutant (G
and H) and the corresponding wild-type strain (E and F), which
express myc-Myo5p, were grown to mid-log phase, fixed, and
stained for myc-Myo5p (E and G) and actin (F and H). Bar, 1 mm.Anderson et al. Myosin I Function and Localization in Yeast 1367
shape, and cell wall deposition are all unaffected. Addi-
tionally, TH2-deleted Myo5p is correctly assembled into
patches and targeted to sites of polarized cell surface
growth. Apparently, partial truncation of the tail alone
does not have any functional consequences and the TH2
domain, as defined, is dispensable for the myosin I func-
tion in actin organization. Alternatively, since a proline-
and alanine-rich region is present carboxy-terminal to the
SH3 domain in Myo5p (see above), it cannot be excluded
that deletion of this region might lead to alteration in
Myo5p behavior.
In contrast to our observations with the TH2 domain,
we find that the SH3 domain of the myosin I tail is re-
quired for optimal Myo5p function in yeast: expression of
mutant MYO5 genes bearing deletions in either the SH3
domain or the SH3 and TH2 domains do not fully comple-
ment loss of MYO3 and MYO5. pSH3D- and pTH2D–
SH3D-expressing cells have defects in actin organization
and reorganization in response to temperature stress. In
addition, these cells grow more slowly in liquid culture and
are sensitive to high temperature (378C) or to high osmotic
strength. Finally, these cells display phenotypes of actin
disorganization including aggregation of mitochondria,
multinucleation, thickened cell walls, and accumulation of
intracellular membranes. The extent of defects in pTH2D–
SH3D-expressing cells is similar to that in pSH3D-express-
ing cells. We attribute the modest difference in the growth
rates of these cells to the fact that the level of Myo5p ex-
pressed from pTH2D-SH3D is slightly lower than that
from pSH3D. These findings support the model that the
TH2 domain is dispensable for myosin I function, and ar-
gue against a role for intramolecular interactions between
the SH3 and TH2 domains of Myo5p in Myo5p regulation.
Moreover, our data indicate that the SH3 domain is re-
quired for normal Myo5p function, consistent with the
finding that the SH3 domain of the classic myosin I of Dic-
tyostelium, myoB, may be required for myoB function in
cell migration (Novak and Titus, 1997).
The SH3 domain, a module which mediates protein–
protein interactions, has been postulated to have diverse
functions including control of protein activity, localization,
and association with the cytoskeleton (refer to Introduc-
tion). Our studies indicate that SH3 contributes to Myo5p
function through control of Myo5p localization. In bud-
ding yeast and in other organisms, classic myosin I pro-
teins are resolved in patch-like structures, consistent with
the assumption that these proteins are associated with
some macromolecular complex. These myosin I–contain-
ing patches are localized at the cell cortex and are en-
riched at sites of actin organization and/or polarization.
Here, we show that deletion of the SH3 domain of Myo5p
produces defects in Myo5p localization. Wild-type and
SH3-deleted forms of Myo5p are resolved as punctate
structures localized at the cell periphery. Deletion of the
SH3 domain results in depolarization of Myo5p patches.
Thus, the SH3 domain of Myo5p is not required for
Myo5p patch assembly. However, our findings indicate
that the SH3 domain contributes to enrichment of Myo5p
at sites of polarized cell surface growth. This observation is
consistent with previous findings that a classic myosin I of
Acanthamoeba, myosin IC, contains an SH3 domain and
colocalizes with the proline-rich myosin IC-binding pro-
tein Acan125 (Xu et al., 1995). Since Myo5p patches do
not colocalize with the actin cytoskeleton, our findings
support a role for the SH3 domain in targeting events
which are not strictly directed to the cytoskeleton.
Previous studies indicate that proteins which act early in
the polarity establishment pathway (Vrp1p, Bem1p, and
Cdc42p) and proteins which act during cytokinesis (septin
proteins Cdc10p and Cdc11p) do not require actin for lo-
calization. In contrast, actin-binding proteins (Abp1p and
cofilin), and secretory proteins known to interact with ac-
tin (Sec4p and Sec8p) require actin for their localization
(Ayscough et al., 1997; Vaduva et al., 1997). We find that
Vrp1p, a proline-rich protein implicated in establishment
of cell polarity, is a possible Myo5p binding partner. Two-
hybrid tests document specific binding between the SH3
domains of both myosin I proteins of yeast and Vrp1p. In-
deed, this assay for protein–protein interaction indicates
that the SH3 domains of Myo3p and Myo5p can bind to
multiple sites on Vrp1p. Since mutation of a conserved
tryptophan residue conserved in the Myo3p SH3 domains
abolished this interaction (data not shown), two-hybrid in-
teraction between Vrp1p and the myosin I SH3 domain
appears to be specific.
Several findings indicate that Vrp1p has functionally sig-
nificant interactions with yeast myosin I proteins. First, we
find that Myo5p colocalizes and coimmunoprecipitates
with Vrp1p. Second, deletion of the VRP1 gene results in
phenotypes that are similar to those of myosin I double
deletion mutants: both mutants show actin cytoskeletal de-
polarization and defects in actin dependent functions in-
cluding endocytosis, bud site selection, and mitochondrial
organization (Vaduva et al., 1997). Third, deletion of
VRP1 results in depolarization of both actin patches
(Vaduva et al., 1997) and Myo5p patches. These observa-
tions support the model that Vrp1p binding to the SH3 do-
main of myosin I proteins contributes to (a) targeting of
myosin I proteins to sites of polarized cell surface growth,
and (b) myosin I function in control of actin organization.
We propose that Vrp1p functions as a proline-rich scaffold
that binds to multiple myosin I proteins and concentrates
Figure 11. Vrp1p coimmunoprecipitates with Myo5p. Yeast
strains that express no tagged constructs (HA10-1b), myc-tagged
Myo5p (HA31-9c bearing pMYO5), or myc-tagged Myo5p and
HA-tagged Vrp1p (VHA-1 bearing pMYO5) were grown to mid-
log phase, disrupted, and then subjected to immunoprecipitation
in the presence and absence of anti-myc antibody. Recovery of
myc-tagged Myo5p was confirmed by Western blot analysis using
anti-myc antibodies (left). Coimmunoprecipitation of HA-tagged
Vrp1p with myc-tagged Myo5p was evaluated by decorating the
same blot with anti-HA antibodies (right). The first lanes of each
blot are whole cell lysates from VHA-1 bearing pMYO5 that il-
lustrate the presence and electrophoretic mobility of tagged pro-
teins.The Journal of Cell Biology, Volume 141, 1998 1368
these proteins at sites of polarized cell surface growth.
Since multiple proline-rich proteins including Srv2p and
Bni1p are localized at sites of polarized cell surface growth
(Freeman et al., 1996; Evangelista et al., 1997) it is possible
that multiple SH3-mediated protein–protein interactions
contribute to myosin I targeting in yeast.
Several findings indicate that the SH3 domain contrib-
utes to, but is not sufficient for, Myo5p targeting. First,
pSH3D-expressing cells show only partial loss of actin or-
ganization and only partial defects in actin dependent pro-
cesses. That is, deletion of the SH3 domain results in a
decrease in the efficiency of Myo5p function in actin orga-
nization. Thus, some fraction of the SH3-deleted Myo5p
must reach the correct site of action. Indeed, we find that
patches containing SH3-deleted Myo5p are present but
are not enriched at sites of polarized cell surface growth.
Second, we find that a fusion protein containing of the
SH3 domain of Myo5p shows diffuse cytosolic staining
when expressed in yeast at levels comparable to wild-type,
endogenous Myo5p. Thus, the SH3 domain is sufficient
neither for the assembly of Myo5p patches, nor for Myo5p
patch polarization. Together, these observations indicate
that multiple factors in addition to the SH3 domain are re-
quired for Myo5p assembly and targeting. Indeed, since
the SH3 domain of myoB, a myosin I protein of Dictyoste-
lium, is not required for myoB targeting (Novak and Titus,
1997), it is possible that the relative contribution of the
SH3 domain to myosin I targeting may vary among cell
types.
One region that may participate in Myo5p targeting is
its TH1 sequence, a highly basic region found in all myosin
I subclasses. Previous studies indicate that the TH1 do-
main of myosin proteins can bind to acidic phospholipids
(Adams and Pollard, 1989; Doberstein and Pollard, 1992).
Moreover, the basic TH1 region of brush border myosin I
protein is sufficient to target myosin molecules to actin-
rich apical structures (Footer and Bretscher, 1994). We
find that deletion of the hyperbasic segment of the Myo5p
TH1 region, or deletion of the motor domain of Myo5p,
impairs protein expression and/or stability (Swayne, T.,
and L. Pon, unpublished results). Therefore, we cannot
draw conclusions regarding the role of the TH1 region in
Myo5p targeting from this line of experiments.
Another region that may participate in Myo5p targeting
is the actin-binding motor domain. We find that Myo5p
patch assembly requires F-actin. LAT-A treatment results
in rapid, quantitative actin depolymerization in yeast and
also produces a decrease in total staining intensity of myc-
tagged Myo5p in punctate structures and an increase in
diffuse, cytosolic staining. Myo5p-containing patches that
are detected are cortical, but delocalized and equally dis-
tributed in mother and daughter cells. Thus, a drug that
causes F-actin depolymerization produces partial defects
in Myo5p patch assembly and defects in enrichment of
Myo5p patches at sites of polarized cell surface growth.
Since myosins are actin-binding proteins, the simplest in-
terpretation of this finding is that Myo5p patch assembly
requires association of Myo5p with F-actin, presumably
through its high-affinity F-actin binding site in the motor
domain. Current studies focus on analysis of the actin-
binding activity of the Myo5p motor domain, and the role
of this activity in Myo5p targeting.
The data we present supports a model for myosin I lo-
calization and function in yeast. In this model, Myo5p is
assembled into a protein complex at the cell cortex. As-
sembly of cortical Myo5p patches does not require either
the TH2 domain or the SH3 domain of the Myo5p tail.
However, Myo5p patch assembly is at least partially de-
pendent upon F-actin. Cortical Myo5p patches are ulti-
mately transported to and concentrated at sites of polar-
ized cell surface growth where they function in polarization
of the actin cytoskeleton. This final targeting event re-
quires the SH3 domain of the Myo5p tail, a region that
binds to Vrp1p. We propose that Vrp1p serves as a scaf-
fold to bind and concentrate Myo5p patches within the
bud. This is the first example of protein-mediated localiza-
tion of a myosin I protein. Moreover, since Vrp1p has
been implicated in actin polarization, our finding provides
(a) additional support for a role of myosin I in actin polar-
ization, and (b) an important link between the cell polarity
machinery and a mediator of actin organization.
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